The Food & Drug Administration's recent approval of process analytical technology (PAT) for use in the pharmaceutical industry is being hailed by drug manufacturers because it encourages process ...

In the context of current good manufacturing practice (cGMP), a number of pharmaceutical manufacturers are incorporating Process Analytical Technologies (PAT), Quality by Design (QbD), or Process ...

Improving product quality and lowering costs are the key factors behind the decisions made in many industries. Ensuring product quality throughout the manufacturing process can be time-consuming, with ...

Cell therapy developers need purpose-built process monitoring technologies, according to researchers who say better systems would accelerate manufacturing and reduce costs. The conclusion is based on ...

As part of current good manufacturing practice (cGMP), many pharmaceutical manufacturers are adopting Process Analytical Technologies (PAT), Quality by Design (QbD), or Process Validation (PV) to ...

Expansive growth in the gene and cell therapy (GCT) space has led to developers and manufacturers facing a multitude of challenges on the road to commercialization. To overcome issues associated with ...

The combination of scanning electron microscopy (SEM) images and energy-dispersive X-ray spectroscopy (EDS) maps (SEM–EDS analysis) enables the analysis of the relationship between the microstructures ...

A new product category called analytic process automation (APA) is changing corporate culture to empower more people with data-driven insights, not just highly trained data scientists. The expansion ...

Business process analysis (BPA) is a methodology that helps organizations deeply examine internal processes to find opportunities for improvement. BPA helps to identify processes that can be made more ...